Emergen Research has recently added a new report titled Global Liquid Biopsy Market that provides an extensive analysis of the Liquid Biopsy market and industry overview with regards to market size, market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments, and a comprehensive analysis of the impact of COVID-19 pandemic on the growth of the Liquid Biopsy market. The report aims to offer a clear understanding of the market with respect to the manufacturers, suppliers, vendors, distributors, and key companies involved in the market. The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals. The key findings from the report have been sorted into charts, figures, tables, and other pictorial representations.
The global liquid biopsy market size is expected to reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the forecast period, according to the latest analysis by Emergen Research. Rise in demand for early cancer detection is a key factor driving global liquid biopsy market revenue growth.
Liquid biopsy is a safe and popular procedure carried out during examination of cancer. The procedure is easy and minimally invasive, allows early detection and diagnosis of cancer, and helps in identification of cancer treatment. In addition, growing popularity of non-invasive techniques is driving private and public financing for research in the field of liquid biopsy, which allow medical professionals to discover various aspects of a tumor through a patient’s blood sample. It facilitates medical professionals to understand, which treatments are suitable for patients.
The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.
The report also discusses the key players involved in the market such as Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Inc., RainDance Technologies, Inc., Biocept, Inc., Qiagen N.V., Trovagene, Inc., and F. Hoffmann-La Roche Ltd and others as well as new entrants in the market. It focuses on the recent mergers & acquisitions, joint ventures, collaborations, partnerships, licensing agreements, brand promotions, and product launches, among others. The report also provides details about the company overview, business expansion plans, product portfolio, manufacturing and production capacity, global market position, financial status, and consumer base.
Key insights presented in the report:
- Market revenue shares by major business players, by type, by application, and market scope of global Liquid Biopsy market
- Sales revenue by key players and new entrants
- Competitive analysis of the key players including aspects such as company overview, product or services specification, vendors, and buyers.
- Recent mergers, acquisitions, product launches, recent investments, and joint ventures
- Regional analysis to provide insight to recent trends and opportunities
The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The report also offers a country wise analysis to impart better understanding of the global Liquid Biopsy market with regards to market share, market size, production and consumption ratio, product launches and R&D activities, investment opportunities, and presence of key players in the region.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/34
The report further segments the global Liquid Biopsy market on the basis of product types and applications and provides insights into key factors influencing the revenue growth of the segments.
- Product Outlook (Revenue, USD Billion; 2018–2028)
- Assays Kits
- Instruments
- Services
- Circulating Biomarkers Outlook (Revenue, USD Billion; 2018–2028)
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor Cells (CTCs)
- Extracellular Vesicles (EVs)
- Cell-Free DNA (cfDNA)
- Other Circulating Biomarkers
- Sample Type Outlook (Revenue, USD Billion; 2018–2028)
- Blood Sample based
- Urine Sample based
- Other Bio Fluids based
The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals.
To know more about the report @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market
Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.
Related Insight:
Certified Circular Plastics Market https://www.emergenresearch.com/industry-report/certified-circular-plastics-market
Machine Vision Market https://www.emergenresearch.com/industry-report/machine-vision-market
Transparent Display Market https://www.emergenresearch.com/industry-report/transparent-display-market
Sexual Enhancers Market https://www.emergenresearch.com/industry-report/sexual-enhancers-market
Artificial Grass Market https://www.emergenresearch.com/industry-report/artificial-grass-market